CLINICAL_TRIALS
trial_result
· 2012-05-07
Clinical Trial Update: Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM) [Phase 3]
Summary
A Phase 3 trial comparing Actovegin with placebo in symptomatic diabetic peripheral neuropathy has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nycomed | Conditions: Symptomatic Diabetic Peripheral Polyneuropathy | Phase 3 | Status: COMPLETED